AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...

Alphabet holds triangle support near $316 as EMAs guide price toward bullish breakout. Google’s 400 TPU patents in 2023 strengthen AI hardware leadership over major tech rivals. Research firms like ...

If you thought that the Seattle Seahawks would roll over the Carolina Panthers today without facing any resistance, then you haven't been paying attention to Carolina this season. After upsetting the ...

New Jersey’s Inter-district Public School Choice Program has remained steady over the years, offering the option to a relatively small and consistent number of students, mostly from affluent districts ...

KANSAS CITY, Mo. — The Lenexa Police Department is the latest Johnson County law enforcement agency to adopt the “Blue Envelope Program.” The police department said it’s an initiative designed to ...

Alphabet delivered record Q3-25 results, surpassing $100B in quarterly net revenue and posting 35% YoY earnings growth, driven by AI and cloud momentum. GOOG raised 2025 capex guidance to $91–93B, ...

Google's recently updated Gemini model outperformed rivals, setting off alarm bells at OpenAI. OpenAI CEO Sam Altman issued a "code red," shifting employee priorities to improving ChatGPT. Alphabet's ...

RALEIGH — Money meant to help survivors of Hurricanes Matthew and Florence were bogged down in a “logistical nightmare” leading to wasted funding and years of project delays, according to a recent ...

The U.S. Border Patrol is monitoring millions of American drivers nationwide in a secretive program to identify and detain people whose travel patterns it deems suspicious, The Associated Press has ...

Under the directive of an intelligence program, the U.S. Border Patrol is monitoring millions of American drivers to identify and arrest those accused of suspicious travel patterns. License plates are ...

The MarketWatch News Department was not involved in the creation of this content. MELBOURNE, Australia, Nov. 14, 2025 /PRNewswire/ -- Samson Clinical (Samson), an Australian pharmaceutical company ...